Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
155.17
+1.18 (0.77%)
May 30, 2025, 3:00 PM - Market open
Cardinal Health Stock Forecast
Stock Price Forecast
According to 15 professional analysts, the 12-month price target for Cardinal Health stock ranges from a low of $120 to a high of $170. The average analyst price target of $143.8 forecasts a -7.33% decrease in the stock price over the next year.
Price Target: $143.80 (-7.33%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Cardinal Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 4 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 6 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 14 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $142 → $166 | Buy | Maintains | $142 → $166 | +6.98% | May 5, 2025 |
| UBS | UBS | Strong Buy Maintains $160 → $170 | Strong Buy | Maintains | $160 → $170 | +9.56% | May 2, 2025 |
| Baird | Baird | Buy Maintains $156 → $170 | Buy | Maintains | $156 → $170 | +9.56% | May 2, 2025 |
| UBS | UBS | Strong Buy Maintains $150 → $160 | Strong Buy | Maintains | $150 → $160 | +3.11% | Apr 29, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $150 → $155 | Strong Buy | Maintains | $150 → $155 | -0.11% | Apr 11, 2025 |
Financial Forecast
Revenue This Year
225.43B
from 226.83B
Decreased by -0.61%
Revenue Next Year
246.37B
from 225.43B
Increased by 9.29%
EPS This Year
8.21
from 3.45
Increased by 137.97%
EPS Next Year
9.17
from 8.21
Increased by 11.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 235.6B | 267.9B | 288.6B | ||
| Avg | 225.4B | 246.4B | 264.4B | ||
| Low | 218.0B | 234.3B | 247.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.9% | 18.8% | 17.1% | ||
| Avg | -0.6% | 9.3% | 7.3% | ||
| Low | -3.9% | 4.0% | 0.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.60 | 9.85 | 10.92 | ||
| Avg | 8.21 | 9.17 | 10.21 | ||
| Low | 7.93 | 8.69 | 9.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 149.3% | 20.0% | 19.1% | ||
| Avg | 138.0% | 11.6% | 11.4% | ||
| Low | 129.8% | 5.9% | 6.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.